Analystreport

Autolus Therapeutics plc (NASDAQ: AUTL) had its price target raised by analysts at Truist Financial Co. from $9.00 to $10.00. They now have a "buy" rating on the stock.

Autolus Therapeutics plc - American Depositary Shares  (AUTL) 
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am Check Earnings Report
US:NASDAQ Investor Relations: autolus.com/investor-relations